COMMUNIQUÉS West-GlobeNewswire

-
Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
05/08/2019 -
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
05/08/2019 -
CADScor®System – Significantly more effective than current practice
05/08/2019 -
Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results
05/08/2019 -
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019
05/08/2019 -
Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer
05/08/2019 -
Nexstim NBT® system authorized for commercial distribution in Australia
05/08/2019 -
Share buy-back week 31/2019
05/08/2019 -
Verona Pharma Reports Positive Phase 2 Results with Dry Powder Inhaler Formulation of Ensifentrine in COPD
05/08/2019 -
AB Science provides an update on its masitinib clinical program
05/08/2019 -
AB Science fait le point sur le programme clinique du masitinib
05/08/2019 -
IBA signs contract to install Cyclone® 70 system in South Korea
05/08/2019 -
IBA signe un contrat pour l’installation d’un Cyclone® 70 en Corée du Sud
05/08/2019 -
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update
05/08/2019 -
Study on Performance Data of Idylla™ NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US)
05/08/2019 -
ObsEva SA to Hold Second Quarter 2019 Financial Results and Business Update Call on August 7, 2019
05/08/2019 -
Fagron NV: Turnover increase of 10.6%; REBITDA increased to €55.6 million
05/08/2019 -
Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer
05/08/2019 -
Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
05/08/2019
Pages